PATENT CLAIM ANALYSIS

Application Number: 16150623
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "001000"]

Abstract:
This invention relates to peptidomimetic linkers and anti-body drug conjugates thereof, to pharmaceutical compositions containing them, and to their use in therapy for the prevention or treatment of cancer.

Claim (Index 28):
The compound of  claim 27 , which is represented by the following formula:

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15182429', '15181825', '14305643', '15182444', '15104388']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779353425191974
- 35 USC 102 Novelty (BERT): 0.5407010570312681
- Combined Prediction Score: 0.7554881883759035
- Mean Citation Score: 337.9627200000001
- Max Citation Score: 363.85858
- Similarity Product: 250.4777850438809

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test